Marketing 101: Don’t puff up your product. When it doesn’t live up to the hype, the public won’t trust what you’re selling the next time around. That’s the problem the Biden administration faces as it tries to peddle “bivalent” booster shots for Covid-19.
Vaccines have served a useful purpose by reducing severe illness among the vulnerable and seniors. But many Americans who rolled up their sleeves for the original two-doses and even third ones were led to believe the vaccines would prevent them from getting sick. Many nevertheless fell ill. Some were knocked out for days with flulike symptoms—exactly what they were trying to avoid by getting vaccinated and boosted. Can you blame them for not buying the administration’s pitch that the new and supposedly improved bivalent boosters will “protect” them and their families?
